Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aurel Perren

Showing results (81-90 of 236) with videos related to

Pageof 24
Sort By:
Endocrine Connections|December 13, 2017
Nationwide multicenter study on the management of pulmonary neuroendocrine (carcinoid) tumorsSamira M Sadowski, Emanuel Christ, Benoit Bédat, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2008
Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CTMatthias Miederer, Stefan Seidl, Andreas Buck, et al.
Gut|February 15, 2023
Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancerEva Karamitopoulou, Anna Silvia Wenning, Animesh Acharjee, et al.
Journal of Molecular Endocrinology|January 21, 2014
MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insightsMatthias S Dettmer, Aurel Perren, Holger Moch, et al.
Swiss Medical Weekly|February 15, 2007
Recurrent hypoglycaemia in HIV-positive narcotic addictsPeter Wiesli, Vojtech Pavlicek, Aurel Perren, et al.
Current Oncology Reports|April 15, 2021
Update on Histological Reporting Changes in Neuroendocrine NeoplasmsKonstantin Bräutigam, Antonio Rodriguez-Calero, Corina Kim-Fuchs, et al.
The American Journal of Surgical Pathology|July 25, 2006
Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patientAurel Perren, Peter Wiesli, Sonja Schmid, et al.
The Journal of Clinical Endocrinology and Metabolism|December 3, 2009
Anti insulin-like growth factor I receptor immunoliposomes: a single formulation combining two anticancer treatments with enhanced therapeutic efficiencyConstanze Hantel, Felicitas Lewrick, Sebastian Schneider, et al.
Virchows Archiv : an International Journal of Pathology|September 19, 2015
Interlaboratory variability of MIB1 staining in well-differentiated pancreatic neuroendocrine tumorsAnnika Blank, Laura Wehweck, Ilaria Marinoni, et al.
Endocrine-Related Cancer|May 20, 2025
Impact of multikinase inhibitors in reshaping the treatment of advanced gastroenteropancreatic neuroendocrine tumorsAlexander R Siebenhüner, Julie Refardt, Guillaume P Nicolas, et al.
Pageof 24

Showing results (81-90 of 236) with videos related to

Sort By:
Pageof 24
Endocrine Connections|December 13, 2017
Nationwide multicenter study on the management of pulmonary neuroendocrine (carcinoid) tumorsSamira M Sadowski, Emanuel Christ, Benoit Bédat, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 23, 2008
Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CTMatthias Miederer, Stefan Seidl, Andreas Buck, et al.
Gut|February 15, 2023
Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancerEva Karamitopoulou, Anna Silvia Wenning, Animesh Acharjee, et al.
Journal of Molecular Endocrinology|January 21, 2014
MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insightsMatthias S Dettmer, Aurel Perren, Holger Moch, et al.
Swiss Medical Weekly|February 15, 2007
Recurrent hypoglycaemia in HIV-positive narcotic addictsPeter Wiesli, Vojtech Pavlicek, Aurel Perren, et al.
Current Oncology Reports|April 15, 2021
Update on Histological Reporting Changes in Neuroendocrine NeoplasmsKonstantin Bräutigam, Antonio Rodriguez-Calero, Corina Kim-Fuchs, et al.
The American Journal of Surgical Pathology|July 25, 2006
Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patientAurel Perren, Peter Wiesli, Sonja Schmid, et al.
The Journal of Clinical Endocrinology and Metabolism|December 3, 2009
Anti insulin-like growth factor I receptor immunoliposomes: a single formulation combining two anticancer treatments with enhanced therapeutic efficiencyConstanze Hantel, Felicitas Lewrick, Sebastian Schneider, et al.
Virchows Archiv : an International Journal of Pathology|September 19, 2015
Interlaboratory variability of MIB1 staining in well-differentiated pancreatic neuroendocrine tumorsAnnika Blank, Laura Wehweck, Ilaria Marinoni, et al.
Endocrine-Related Cancer|May 20, 2025
Impact of multikinase inhibitors in reshaping the treatment of advanced gastroenteropancreatic neuroendocrine tumorsAlexander R Siebenhüner, Julie Refardt, Guillaume P Nicolas, et al.
Pageof 24